Search clinical trials for: Placebo Varenicline

Total 53630 results

NYU Langone Health
Pfizer

Withdrawn

Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt (VarenSmoke)

Nicotine Dependence

United States
Oyster Point Pharma, Inc.

Completed

Evaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Varenicline

Healthy Subjects

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation. (ECSMOKE)

Smoking Cessation | Smoking, Cigarette | Electronic Cigarette

France
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers

Methamphetamine Addiction | Crystal Meth Addiction | Amphetamine Addiction

United States
American University of Beirut Medical Center
Pfizer

Completed

Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation

Nicotine Dependence

Lebanon
Arizona State University
National Institute on Drug Abuse (NIDA); Pfizer; University of Nevada, Reno; Los...

Completed

Varenicline OTC Trial on Efficacy and Safety (VOTC)

Smoking Cessation | Withdrawal Symptoms | Tobacco Dependence

United States
Pfizer

Withdrawn

A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation

Smoking Cessation
Pfizer

Completed

Smoking Cessation Study In Healthy Adolescent Smokers

Smoking Cessation

United States, Korea, Republic of, Taiwan, Canada, Georgia, Russian Federation
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Terminated

A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation

Nicotine Addiction

United States
University of South Florida
Pfizer; National Ataxia Foundation; Bob Allison Ataxia Research Center (BAARC)

Completed

Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3

Spinocerebellar Ataxia Type 3

United States
Pfizer

Completed

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

Smoking Cessation

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); Pfizer; National Institutes of Health...

Active, not recruiting

A Trial of Directly Observed and Long-term Varenicline

Tobacco Use Disorder | Opioid-use Disorder

United States
Amsterdam UMC, location VUmc
Centre for Human Drug Research, Netherlands

Terminated

Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease (VESPA)

Parkinson's Disease

Netherlands
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

China
Roswell Park Cancer Institute
Pfizer

Completed

An Alternative Dosing Schedule of Varenicline for Smoking Cessation

Smoking Cessation

United States
Memorial Sloan Kettering Cancer Center
Pfizer

Terminated

Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)

Breast Cancer | Tobacco Dependence

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Completed

Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement

Tobacco Dependence

United States
Nathan Kline Institute for Psychiatric Research

Completed

Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors

Schizophrenia | Cigarette Smoking

United States, China, Israel
Johns Hopkins University
Pfizer

Completed

Relapse Prevention With Varenicline (0815)

Substance-Related Disorders | Smoking Cessation | Recurrence

United States
Pfizer

Completed

Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo

Smoking Cessation

United States
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)

Dry Eye Disease

Mexico
University of South Florida
Pfizer; Friedreich's Ataxia Research Alliance

Terminated

Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia

Friedreich's Ataxia

United States
Sahlgrenska University Hospital, Sweden
Karolinska University Hospital; Malmö University

Completed

Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?

Alcohol Dependence

Sweden
Mayo Clinic
National Institutes of Health (NIH)

Completed

Varenicline for the Treatment of Smokeless Tobacco (CHANCHEW)

Nicotine Dependence

United States
Pfizer

Completed

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Smoking Cessation

United States, France, Italy, Spain
Pfizer

Withdrawn

A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia

Schizophrenia
University Hospital, Gentofte, Copenhagen
Pfizer

Unknown

Varenicline for Long-term Nicotine Replacement Therapy (NRT) Users

Tobacco Dependence

Denmark
Mark Eisenberg
Sunnybrook Health Sciences Centre; Unity Health Toronto; Queen Elizabeth II Health...

Completed

Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial (EVITA)

Acute Coronary Syndrome

Canada
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Varenicline for Smoking Cessation in Heavy Drinking Smokers

Smoking | Nicotine Dependence | Heavy Drinking
Yale University

Active, not recruiting

Varenicline for Treatment of E-cigarette Dependence

Smoking Cessation

United States
Pfizer

Completed

Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date

Smoking Cessation

United States, Czech Republic, Korea, Republic of, Brazil, Taiwan, Mexico, France, Italy, Hungary, Germany, Canada, China, Argentina, United Kingdom
Pfizer

Completed

Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

Depression | Smoking Cessation

Spain, United States, Hungary, Germany, Bosnia and Herzegovina, Croatia, Romania, Russian Federation
Pfizer

Completed

Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects

Healthy | Non-Smoking

United States
Vance Thompson Vision - MT

Not yet recruiting

IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL

Dry Eye Disease

United States
University of Maryland, Baltimore
National Institute on Drug Abuse (NIDA)

Completed

Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia

Schizophrenia | Cigarette Smoking
Universita degli Studi di Catania

Completed

Efficacy And Safety Of Smoking Cessation With Varenicline Tartrate In Diabetic Smokers: (DIASMOKE) (DIASMOKE)

Smoking Cessation | Diabetes

Italy
Medical University of South Carolina

Completed

UH3 Varenicline for Cannabis Use Disorder

Cannabis Use Disorder

United States
Pfizer

Completed

A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days

Smoking Cessation

United States
Korea University Anam Hospital

Completed

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502

Healthy

Korea, Republic of
Butler Hospital
Brown University

Completed

Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers

Depressive Disorder | Smoking

United States
Pfizer

Completed

An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

Smoking Cessation

Thailand, Singapore, China
Pfizer

Completed

A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction

Smoking Cessation

United States, Taiwan, Australia, Germany, Egypt, United Kingdom, Canada, Czech Republic, Mexico, Japan
Medical University of South Carolina

Completed

Hollings Cancer Center Varenicline Sampling Study

Smoking | Smoking Cessation | Smoking, Tobacco | Smoking, Cigarette

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Enrolling by invitation

Cessation Screening Project

Nicotine Dependence

United States
University of Stellenbosch
QuitSupport

Completed

Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation

Tobacco Dependence

South Africa
University of Kansas Medical Center

Recruiting

Switching to E-cigarettes in African-American Smokers

Smoking Reduction

United States
Oyster Point Pharma, Inc.

Completed

Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease (DED)

United States
Oyster Point Pharma, Inc.

Completed

Evaluation of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

United States
University of California, San Francisco
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

A Pilot Clinical Trial of Varenicline as a Treatment for Alcohol Dependence

Substance Dependence

United States
Pfizer

Completed

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Smoking Cessation

United States, Canada

Search clinical trials for: Placebo Varenicline

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations